sumatriptan has been researched along with guaifenesin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huber, VJ; Nakada, T; Tsujita, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arnaud, P; Botham, R; Lenfant, B; Pachot, J; Pontier, C | 1 |
1 review(s) available for sumatriptan and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for sumatriptan and guaifenesin
| Article | Year |
|---|---|
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
Topics: Aquaporin 4; Computer Simulation; Humans; Inhibitory Concentration 50; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2009 |
HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.
Topics: Administration, Oral; Biological Transport, Active; Caco-2 Cells; Cell Membrane Permeability; Cell Size; Cimetidine; Diffusion; Forecasting; HT29 Cells; Humans; Intercellular Junctions; Intestinal Absorption; Intestinal Mucosa; Methotrexate; Microscopy, Electron, Scanning; Microvilli; Models, Biological; Mucus; Sumatriptan | 2001 |